J, C., L, D., A, G., H, Z., W, T., JC, F., . . . Z, Q. (2019). Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation. PLoS pathogens, 15(12), e1008156. https://doi.org/10.1371/journal.ppat.1008156
Chicago Style (17th ed.) CitationJ, Chen, Dai L, Goldstein A, Zhang H, Tang W, Forrest JC, Post SR, Chen X, and Qin Z. "Identification of New Antiviral Agents Against Kaposi's Sarcoma-associated Herpesvirus (KSHV) by High-throughput Drug Screening Reveals the Role of Histamine-related Signaling in Promoting Viral Lytic Reactivation." PLoS Pathogens 15, no. 12 (2019): e1008156. https://doi.org/10.1371/journal.ppat.1008156.
MLA (9th ed.) CitationJ, Chen, et al. "Identification of New Antiviral Agents Against Kaposi's Sarcoma-associated Herpesvirus (KSHV) by High-throughput Drug Screening Reveals the Role of Histamine-related Signaling in Promoting Viral Lytic Reactivation." PLoS Pathogens, vol. 15, no. 12, 2019, p. e1008156, https://doi.org/10.1371/journal.ppat.1008156.
